The current status of chemoprevention in FAP

Familial Cancer

Volumn 5, Issue 3, 2006, Pages 289-294

  Wallace, M H ^a   Lynch, P M ^b  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Celecoxib; Chemoprevention; Polyposis; Selective COX 2 inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; APC PROTEIN; ASCORBIC ACID; CALCIUM; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; EFLORNITHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ROFECOXIB; STARCH; SULINDAC;

ADENOMATOUS POLYP; CANCER PREVENTION; CANCER SURGERY; CANCER THERAPY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DIET THERAPY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DUODENUM POLYP; FAMILIAL CANCER; GENE REPLACEMENT THERAPY; HUMAN; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; RECTUM POLYP; REVIEW; SPICE; TUMOR REGRESSION; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

ADENOMATOUS POLYPOSIS COLI; ANTINEOPLASTIC AGENTS; CHEMOPREVENTION; HUMANS;

EID: 33749021639     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-005-5676-0     Document Type: Review

References (28)

1. KP Nugent AD Spigelman RKS Phillips 1993 Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis Dis Colon Rectum 36 1059 62
2. HH Miller LJ Bauman DR Friedman 1986-87 Psychosocial adjustment of familial polyposis patients and participation in a chemoprevention trial Int J Psychiatry Med 16 3 211 30
3. WR Waddell RW Longhry 1983 Sulindac for polyposis of the colon J Surg Oncology 24 83 7
4. D Labayle D Fischer P Viehl 1991 Sulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology 101 635 9
5. CM Cruz LM Hylind K Romans 2002 Long term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study Gastroenterology 122 3 641 5
6. I Guldenschuh R Hurlimannn A Muller 2001 Relationship between APC genotype, polyp distribution and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis Dis Colon Rectum 44 8 1090 7
7. G Winde HG Gumbinger F Kemper 1993 The NSAID sulindac reverses rectal adenomas in colectomised patients with familial adenaomtous polyposis: Clinical results of a dose-finding study on rectal sulindac administration Int J Colorectal Dis 8 1 13 7
8. CS Richard T Berk BV Bapat 1997 Sulindac for periampullary polyps in FAP patients Int J Colorectal Dis 12 1 14 8
9. HS Debinski J Trojan KP Nugent 1995 Effect of sulindac on small polyps in familial adenomatous polyposis Lancet 345 855 66
10. KP Nugent KCR Farmer AD Spigelman 1993 Randomised controlled trial of the effects of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis Br J Surg 80 1618 9
11. Y Niv GM Fraser 1994 Adenocarcinoma in the rectal remnant in familial polyposis coli is not prevented by sulindac therapy Gastroenterology 107 854 7
12. FM Giardello RA Casero SR Hamilton 2004 Prostanoids, ornithine decarboxylase and polyamines in primary chemoprevention of familial adenomatous polyposis Gastroenterology 49 1259 61
13. T Akasu T Yokoyama K Sugihara 2002 Peroral sustained release indomethacin treatment for rectal adenomas in familial adenomatous polyposis: A pilot study Hepatogastroenterology 49 1259 61
14. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 803 9
15. T Kawamori CV Rao K Seibert 1998 Chemopreventative activity of celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis Ca Res 58 409 12
16. GD Steinbach PM Lynch RKS Phillips 2000 The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 1946 52
17. RKS Phillips MH Wallace PM Lynch 2002 A randomised double blind placebo controlled study of celecoxib, a selective cyclooxygenase -2 inhibitor on duodenal polyposis in familial adenomatous polyposis Gut 50 657 60
18. T Higuchi T Iwama K Yoshinaga 2003 A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients Clin Cancer Res 9 13 4756 60
19. A Hallak L Baron R Samir 2003 Rofecoxib reduces polyp recurrence in familial polyposis Dig Dis Sci 49 10 1998 2002
20. GD Stoner GT Budd R Ganapathi 1999 Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis Adv Exp Med Biol 470 45 53
21. MJ Hill 1975 Metabolic epidemiology of dietary factors in large bowel cancer Cancer Res 35 3398 402
22. JC Mathers I Mickleburgh PC Chapman 2003 Can resistant starch and / or prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 study Proc Nutr Soc 62 51 7
23. JI Lew Y Guo RK Kim 2002 Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive J Gastrointest Surg 6 563 8
24. HJ Bussey JJ DeCosse EE Deschner 1982 A randomized trial of ascorbic acid in polyposis coli Cancer 50 7 1434 9
25. JJ DeCosse HH Miller ML Lesser 1989 Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis J Natl Cancer Inst 81 17 1290 7
26. MG Thomas JP Thomson RC Williamson 1993 Oral calcium inhibits rectal proliferation in familial adenomatous polyposis Br J Surg 80 40 449 501
27. S Perkins RD Verschoyle K Hill 2002 Chemoprevention efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis Cancer Epidemiol Biomarkers Prev 11 535 40
28. SH Erdman NA Ignatenko MB Powell 1999 APC-dependant changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse Carcinogenesis 20 1709 13